Wendy Stock to Chromatin
This is a "connection" page, showing publications Wendy Stock has written about Chromatin.
Connection Strength
0.089
-
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Nat Commun. 2024 May 01; 15(1):3681.
Score: 0.048
-
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. Blood. 2022 06 16; 139(24):3519-3531.
Score: 0.042